Today’s focus of Stock-Callers.com is shifted on four Staffing and Outsourcing Services equities, which are Monster Worldwide Inc. (NYSE: MWW), Robert Half International Inc. (NYSE: RHI), ManpowerGroup Inc. (NYSE: MAN), and Team Health Holdings Inc. (NYSE: TMH). Investment firm Jefferies is bullish on the sector due to growing demand for outsourcing solutions despite structural labor shortages. Download the free research reports on these stocks today:
Shares in Weston, Massachusetts headquartered Monster Worldwide Inc. ended Tuesday’s session at $3.43, which was a slight decline of 0.58%. The stock recorded a trading volume of 3.57 million shares, which was above its three months average volume of 2.07 million shares. The Company’s shares have surged 27.04% in the last one month and 25.18% in the previous three months. The stock is trading 27.14% above its 50-day moving average. Moreover, shares of Monster Worldwide, which together with its subsidiaries, provides online and mobile employment and recruitment solutions worldwide, have a Relative Strength Index (RSI) of 69.20.
On August 9th, 2016, Randstad Holding, a leading human resources services provider, and Monster Worldwide, announced the signing of a definitive agreement under which Randstad will acquire Monster. Under the terms of the merger agreement, Randstad will pay $3.40 per share in cash, or a total purchase price of approximately $429 million. See our free and comprehensive research report on MWW at:
Robert Half Intl.
Menlo Park, California headquartered Robert Half International Inc.’s stock rose 0.21%, closing the day at $37.49 with a total volume of 1.20 million shares traded. Shares of the Company, which provides staffing and risk consulting services in North America, South America, Europe, Asia, and Australia, are trading 2.61% below their 50-day moving average. The stock has an RSI of 46.55.
On July 26th, 2016, Robert Half International reported that for the quarter ended June 30th, 2016, net income was $92 million, or $.71 per share, on revenues of $1.34 billion. Net income for the prior year’s Q2 was $90 million, or $.67 per share, on revenues of $1.27 billion. The company noted that in Q2, unlevered return on equity for the company was 35%.
On July 27th, 2016, research firm RBC Capital Markets reiterated its ‘Outperform’ rating on the Company’s stock with a decrease of the target price from $48 a share to $42 a share. RHI free research report PDF is just a click away at:
On Tuesday, shares in Milwaukee, Wisconsin headquartered ManpowerGroup Inc. recorded a trading volume of 719,430 shares. The stock ended the day 1.48% lower at $69.44. The Company’s shares have gained 1.71% in the past month and are trading below their 50-day moving average by 0.02%. Furthermore, shares of ManpowerGroup, which provides workforce solutions and services in the Americas, Southern Europe, Northern Europe, and the Asia Pacific Middle East region, have an RSI of 49.55.
On July 28th, 2016, ManpowerGroup announced that its Board of Directors has authorized a new share repurchase program under which the company may repurchase up to 6 million shares of its common stock. The new repurchase program is in addition to the share repurchase program authorized in October 2015. Under that program, the Company repurchased approximately 0.7 million shares in 2015 and 3.8 million shares in the first two quarters of 2016, leaving approximately 1.5 million shares of remaining capacity as of June 30th, 2016. Sign up for your complimentary report on MAN at:
Team Health Holdings
Knoxville, Tennessee headquartered Team Health Holdings Inc.’s stock saw a drop of 3.00%, finishing yesterday’s session at $35.24 and with a total volume of 543,167 shares traded. Shares of the Company, which provides outsourced healthcare professional staffing and administrative services to hospitals and other healthcare providers in the US, are trading below their 50-day moving average by 15.34%. The stock has an RSI of 27.67.
On August 2nd, 2016, Team Health Holdings reported that Q2 2016, net revenue increased 27.9% to $1.12 billion from $878.0 million, in Q2 2015. IPC contributed 21.1%, legacy (non-IPC) acquisitions contributed 3.1%, same contract revenue contributed 2.4%, and net new growth contributed 1.2% of the increase in quarter-over-quarter growth in net revenue. Net earnings attributable to Team Health Holdings, for the reported quarter were $18.8 million, or $0.25 diluted net earnings per share, compared to net earnings of $28.9 million, or $0.39 diluted net earnings per share, in Q2 2015.
On August 11th, 2016, research firm Jefferies upgraded the Company’s stock rating from ‘Hold’ to ‘Buy’. Register for free on Stock-Callers.com and download the latest research report on TMH at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you‘re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA